Boston Scientific is part of the boerse.de-Aktienbrief Plus investment universe, which comprises 246 stocks. In the major trend evaluation of June 17, 2022, the title fell from rank 103 to rank 106.
The model portfolio of the boerse.de-Aktienbrief Plus is controlled by the BOTSI®-Advisor, an investment robot for the active control of stock portfolios, developed according to the latest scientific findings on trend following.
BOTSI® stands for Bis-of-Tgive-System-Investment, whereby the model portfolio of the boerse.de-Aktienbrief Plus controlled by the BOTSI®-Advisor has averaged since 1999 in retrospect 22,1% p.a. and the winner is.
All historical trades are available online. The sample portfolio invests in up to ten top stocks and is easy to replicate. With the free and completely non-binding login for the boerse.de-Aktienbrief Plus you will have full access to the huge online area and the latest recommendations in just a few minutes. You too can benefit from the trendiest top stocks!
Request a risk-free login now!